[预防新生儿常见呼吸道病毒感染的专家建议]
[Expert recommendations for the prevention of common respiratory viral infections in neonates].
出版信息
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Aug 15;26(8):789-794. doi: 10.7499/j.issn.1008-8830.2405078.
Abstract
Neonates, particularly preterm infants, are a susceptible population to respiratory viral infections. Currently, aside from influenza, there are no antiviral medications specifically approved for the treatment of respiratory viral infections in neonates; therefore, prevention of these viral infections is particularly crucial for neonates. The Neonatal HealthCare Committee of Chinese Maternal and Child Health Association, based on domestic and international clinical evidence and combined with clinical practice experience, and after thorough discussion by relevant experts, has developed eight expert recommendations. These include preventive strategies against influenza virus, respiratory syncytial virus, and severe acute respiratory syndrome coronavirus 2 infections, intended for reference in clinical practice.
摘要
新生儿，尤其是早产儿，是呼吸道病毒感染的易感人群。目前，除流感外，尚无专门批准用于治疗新生儿呼吸道病毒感染的抗病毒药物；因此，预防这些病毒感染对新生儿尤为关键。中国妇幼保健协会新生儿保健专业委员会基于国内外临床证据，结合临床实践经验，经相关专家充分讨论，制定了八项专家建议。这些建议包括针对流感病毒、呼吸道合胞病毒和严重急性呼吸综合征冠状病毒2感染的预防策略，供临床实践参考。
相似文献
1
[Expert recommendations for the prevention of common respiratory viral infections in neonates].[预防新生儿常见呼吸道病毒感染的专家建议]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Aug 15;26(8):789-794. doi: 10.7499/j.issn.1008-8830.2405078.
2
What U.S. Obstetricians Need to Know About Respiratory Syncytial Virus.美国妇产科医生须知：呼吸道合胞病毒
Obstet Gynecol. 2024 Mar 1;143(3):e54-e62. doi: 10.1097/AOG.0000000000005492. Epub 2023 Dec 7.
3
Impact of SARS-CoV-2 Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis From 2015-2023.SARS-CoV-2 预防措施对非 SARS-CoV-2 医院获得性呼吸道病毒感染的影响：2015-2023 年发病趋势分析。
Clin Infect Dis. 2023 Dec 15;77(12):1696-1699. doi: 10.1093/cid/ciad451.
4
Maternal vitamin D supplementation during pregnancy and lactation to prevent acute respiratory infections in infancy in Dhaka, Bangladesh (MDARI trial): protocol for a prospective cohort study nested within a randomized controlled trial.孟加拉国达卡孕期和哺乳期母亲补充维生素D预防婴儿期急性呼吸道感染（MDARI试验）：一项嵌套于随机对照试验中的前瞻性队列研究方案
BMC Pregnancy Childbirth. 2016 Oct 13;16(1):309. doi: 10.1186/s12884-016-1103-9.
5
Common (but not always considered) viral infections of the lower respiratory tract.常见的（但并非总是被考虑到的）下呼吸道病毒感染。
Pediatr Ann. 1996 Oct;25(10):577-84. doi: 10.3928/0090-4481-19961001-10.
6
[Expert recommendations for the prevention and control of pediatric respiratory syncytial virus infections in China (2023 edition)].《中国儿童呼吸道合胞病毒感染预防与控制专家建议（2023年版）》
Zhonghua Yi Xue Za Zhi. 2023 Oct 31;103(40):3155-3159. doi: 10.3760/cma.j.cn112137-20230712-01213.
7
Vaccines for the prevention of respiratory viral infections: problems and current status.预防呼吸道病毒感染的疫苗：问题与现状
Expert Opin Investig Drugs. 2004 Jun;13(6):681-9. doi: 10.1517/13543784.13.6.681.
8
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates.帕利珠单抗用于预防早产儿呼吸道合胞病毒感染。
Klin Padiatr. 2017 Sep;229(5):259-260. doi: 10.1055/s-0043-116334. Epub 2017 Sep 19.
9
[Infections with respiratory viruses].[呼吸道病毒感染]
Ther Umsch. 1994 Aug;51(8):563-8.
10
Prophylaxis, therapy and prevention of viral respiratory infections.病毒性呼吸道感染的预防、治疗与防控
Paediatr Respir Rev. 2004;5 Suppl A:S185-9. doi: 10.1016/s1526-0542(04)90035-8.
本文引用的文献
1
An Observational Study on the Pharmacokinetics of Oseltamivir in Lactating Influenza Patients.一项关于哺乳期流感患者奥司他韦药代动力学的观察性研究。
Clin Pharmacol Ther. 2024 Feb;115(2):318-323. doi: 10.1002/cpt.3107. Epub 2023 Dec 3.
2
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《使用尼赛珠单抗预防婴幼儿呼吸道合胞病毒疾病：免疫实践咨询委员会的建议-美国，2023 年》。
MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):920-925. doi: 10.15585/mmwr.mm7234a4.
3
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.孕期接种二价融合前F疫苗预防婴儿呼吸道合胞病毒疾病
N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5.
4
[Perinatal and neonatal management plan for prevention and control of SARS-CoV-2 infection (3rd Edition)].[新型冠状病毒2019感染防控围产期及新生儿管理方案（第3版）]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jan 15;25(1):1-4. doi: 10.7499/j.issn.1008-8830.2212074.
5
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.尼塞利珠单抗预防早产儿和足月儿呼吸道合胞病毒下呼吸道感染的疗效，以及对伴有先天性心脏病和慢性肺部疾病的婴儿的药代动力学外推：一项随机对照试验的汇总分析。
Lancet Child Adolesc Health. 2023 Mar;7(3):180-189. doi: 10.1016/S2352-4642(22)00321-2. Epub 2023 Jan 9.
6
Inactivation of SARS-CoV-2 by Commercially Available Disinfectants and Cleaners.商业消毒剂和清洁剂对 SARS-CoV-2 的灭活作用。
Biocontrol Sci. 2022;27(4):223-228. doi: 10.4265/bio.27.223.
7
Effectiveness of on-site influenza vaccination strategy in Italian healthcare workers: a systematic review and statistical analysis.意大利医护人员现场流感疫苗接种策略的有效性：系统评价与统计分析
Expert Rev Vaccines. 2023 Jan-Dec;22(1):17-24. doi: 10.1080/14760584.2023.2149500. Epub 2022 Nov 22.
8
Recommendations for Prevention and Control of Influenza in Children, 2022-2023.2022-2023 年度儿童流感预防和控制建议。
Pediatrics. 2022 Oct 1;150(4). doi: 10.1542/peds.2022-059274.
9
COVID-19 in Neonates with Positive RT-PCR Test. Systematic Review.新生儿 COVID-19 阳性 RT-PCR 检测结果。系统评价。
Arch Med Res. 2022 Apr;53(3):252-262. doi: 10.1016/j.arcmed.2022.03.001. Epub 2022 Mar 14.
10
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.尼塞维单抗用于患有心脏或肺部疾病或早产的婴儿预防呼吸道合胞病毒感染的安全性
N Engl J Med. 2022 Mar 3;386(9):892-894. doi: 10.1056/NEJMc2112186.
Zotero 插件